BRIEF-Richter signs deal with DM Bio for biosimilar cancer medicine

October 19, 2016 6:15 AM

29 0

* Has signed an agreement with DM Bio for development and sale of biosimilar medicine trastuzumab.

* Trastuzumab designed for the treatment of an aggressive form of breast cancer as well as a form of metastatic gastric cancer.

Also read: AT&T in Talks to Acquire AppNexus for About $1.6 Billion

Read more

To category page